Ridgeback Capital
Crossover fundMiami Β· SeedβLate Stage Β· 1 people tracked
Also known as MANDALAY FINANCIAL, L.L.C.
Investment thesis
Ridgeback Capital invests in private and public healthcare companies dedicated to developing transformative, life-saving and life-changing therapies. The firm emphasizes patient capital, reflecting founder Dr. Wayne Holman's belief that meaningful healthcare advances often take many years to materialize and require long-term backing for new technologies and companies to succeed. Over more than two decades, the firm's principal has funded over 100 public and private biopharma companies supporting research and development addressing unmet medical needs.
Source: firm website, verified Aug 3, 2026.
Team Β· 1 people
from the firm's websiteWhat they invest in
from 5 of 18 portfolio companiesBiotech Γ5Medical Devices Γ4Healthtech Γ3Digital Health Γ1
HQs:United StatesΓ3
Investments Β· 18 tracked
founders shown can be your intro pathMacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients, including oncology, hematology, and autoimmune applications.
BiotechMedical Devices
Adaptimmune Therapeutics is a biotechnology company, though the specific focus of their therapeutic work is not detailed on this investors and media page.
BiotechHealthtechMedical Devices
Gilead discovers, develops, and delivers innovative therapeutics for people with life-threatening diseases, focusing on virology, oncology, and inflammation across more than 35 countries.
BiotechDigital HealthHealthtechMedical DevicesFoster City, US
Lou Lange(Founder)
Regeneron discovers, develops, and manufactures biologics and genetic medicines for treating serious diseases including metabolic disorders, ophthalmology conditions, and rare diseases.
BiotechHealthtechMedical DevicesTarrytown, US
Frequently asked questions
- What stage does Ridgeback Capital invest at?
- Ridgeback Capital invests at the Seed, Late Stage stages.
- What sectors does Ridgeback Capital focus on?
- Ridgeback Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Ridgeback Capital located?
- Ridgeback Capital is headquartered in Miami, US.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.